|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Improving the decision-making process in structural modification of drug candidates :reducing toxicity显示文摘 | NASSAR AE KAMEL AM CLARIMONT C | 2004 | Drug Discov Today2004，9，24： | 1 |
| 2 | Improving the decision-making process in structural modification of drug candidates: reducing toxicity显示文摘 | Nassar AE Kamel AM Clarimont C | 2004 | Drug Discov Today2004，9，24： | 1 |
| 3 | Soluble complement receptor- 1 protects heart, lung, and cardiac myofilament function from cardiop- ulmonary bypass damage 显示文摘 | Chai PJ Nassar R Oakeley AE | 2000 | Circulation2000，101，5： | 1 |
| 4 | Soluble complement receptor1 protects heart,lung,and cardiac myofilament function from cardiopulmonary bypass damage显示文摘 | Chai PJ Nassar R Oakeley AE | | 0，，05： | 1 |
| 5 | Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage 显示文摘 | Chai PJ Nassar R Oakeley AE | 2000 | Circulation2000，101，5： | 1 |
| 6 | Soluble complement receptor-1 protects heart,lung,and cardiac myofilament function from cardiopulmonary bypass damage显示文摘 | Chai PJ Nassar R Oakeley AE | 2000 | Circulation2000，101，5： | 1 |
| 7 | Soluble complement receptor - 1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage 显示文摘 | Chai PJ Nassar R Oakeley AE | 2000 | Circulation2000，101，5： | 1 |
| 8 | Soluble complementreceptor-1 protects heart,lung, and cardiac myofilamentfunction from cardiopulmonary bypass damage显示文摘 | Chai PJ Nassar R Oakeley AE | 2000 | Circu-lation2000，101，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员